<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We designed the present study to examine whether or not the inhibition of acetylcholinesterase modulates cerebral microcirculation in <z:hpo ids='HP_0002615'>hypotension</z:hpo> and improves brain metabolism in <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> induced by bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> in hypertensive rats </plain></SENT>
<SENT sid="1" pm="."><plain>Blood flow to the parietal cortex was determined by the H2 clearance method </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="4" ids="24996">Lactate</z:chebi>, <z:chebi fb="1" ids="15361">pyruvate</z:chebi>, and ATP were estimated by enzymatic methods </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="38462">Acetylcholinesterase inhibitor</z:chebi> (AChEI, ENA-713), at 0.05, 0.1, or 0.5 mg/kg, was intravenously injected 10 min before either hemorrhagic <z:hpo ids='HP_0002615'>hypotension</z:hpo> or <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The levels of <z:chebi fb="9" ids="15355">acetylcholine</z:chebi> in the control were 29.3 +/- 8.1 (mean +/- SD) and 39.5 +/- 8.1 pmol/mg in the cortex and hippocampus, respectively, and they were significantly decreased by 15-19% after 60 min of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in the vehicle-treated rats </plain></SENT>
<SENT sid="5" pm="."><plain>AChEI preserved the levels to 93-98% of the control (p &lt; 0.05 versus vehicle) </plain></SENT>
<SENT sid="6" pm="."><plain>The lower limit of autoregulation was 74 +/- 9% of the resting values </plain></SENT>
<SENT sid="7" pm="."><plain>The administration of AChEI helped preserve blood flow and lowered the limit to 64 +/- 6% (p &lt; 0.05 versus control) </plain></SENT>
<SENT sid="8" pm="."><plain>After 60 min of <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, <z:chebi fb="4" ids="24996">lactate</z:chebi> increased 6.5-fold and ATP decreased to 64% of the control value </plain></SENT>
<SENT sid="9" pm="."><plain>The administration of AChEI dose-dependently reduced the <z:chebi fb="4" ids="24996">lactate</z:chebi> level 1.9- to 3.9-fold and well preserved the ATP level to 94-97% of the control </plain></SENT>
<SENT sid="10" pm="."><plain>The inhibition of acetylcholinesterase activity may preserve cerebral autoregulation during <z:hpo ids='HP_0002615'>hypotension</z:hpo> and protect cerebral metabolism against ischemic insult </plain></SENT>
</text></document>